跳至主要内容
临床试验/NCT01076569
NCT01076569已完成不适用

Target: Identification for High Risk Childhood AML Based on Genome-Wide Analysis

Children's Oncology Group1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2010年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
250
试验地点
1
主要终点
Detailed molecular map of pediatric high-risk acute myeloid leukemia

研究概览

简要总结

This pilot research trial studies biomarkers in bone marrow samples from pediatric patients with high risk acute myeloid leukemia. Studying samples of bone marrow from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer.

详细描述

PRIMARY OBJECTIVES:

I. To provide a detailed, molecular map of pediatric high risk acute myeloid leukemia (AML).

II. To identify mutations, expression profile, gene copy number, loss of heterozygosity (LOH) status and genomic methylation patterns in order to identify novel changes associated with pediatric AML.

III. To generate fibroblast cell lines in order to obtain germline nucleic acids from marrow specimens from AML patients with induction failure.

IV. To identify genomic alterations contributing to induction failure in childhood AML.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
— 至 21 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of acute myeloid leukemia
  • High-risk disease
  • Treated on COG-AAML03P1 or COG-AAML0531
  • Meets the following criteria:
  • Initial remission with no known adverse risk factors
  • High quantity and quality of ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) available
  • Highly enriched specimens with >= 50% blast available

排除标准

  • 未提供

结局指标

主要结局

Detailed molecular map of pediatric high-risk acute myeloid leukemia

时间窗: Baseline

Mutations in identifying novel changes associated with pediatric AML

时间窗: Baseline

Expression profile in identifying novel changes associated with pediatric AML

时间窗: Baseline

Gene copy number in identifying novel changes associated with pediatric AML

时间窗: Baseline

Genomic methylation patterns in identifying novel changes associated with pediatric AML

时间窗: Baseline

Genomic alterations contributing to induction failure in childhood AML

时间窗: Baseline

LOH status in identifying novel changes associated with pediatric AML

时间窗: Baseline

Genomic and transcriptome alterations associated with induction failure

时间窗: Baseline

次要结局

未报告次要终点

研究者

申办方类型
Network
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验